Bg pattern

SPECTRACEF 200 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SPECTRACEF 200 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: Information for the user

SPECTRACEF 200 mg film-coated tablets

Cefditoren

Read this leaflet carefully before starting to take this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What SPECTRACEF 200 mg film-coated tablets are and what they are used for
  2. What you need to know before taking SPECTRACEF 200 mg film-coated tablets
  3. How to take SPECTRACEF 200 mg film-coated tablets
  4. Possible side effects
  5. Storage of SPECTRACEF 200 mg film-coated tablets
  6. Package contents and additional information

1. What SPECTRACEF 200 mg film-coated tablets are and what they are used for

SPECTRACEF belongs to a group of antibiotics called cephalosporins, which work by inhibiting the synthesis of the bacterial cell wall.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or common cold.

It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash.

SPECTRACEF is used in adult patients for the treatment of the following infections:

  • Acute pharyngitis.
  • Acute maxillary sinusitis.
  • Acute exacerbation of chronic bronchitis.
  • Community-acquired pneumonia, mild to moderate.
  • Uncomplicated skin and soft tissue infections, such as cellulitis, infected wounds, abscesses, folliculitis, impetigo, and furunculosis.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking SPECTRACEF 200 mg film-coated tablets

Do not take SPECTRACEF

  • if you are allergic to antibiotics, particularly penicillin or other types of beta-lactam antibiotics, or to any of the other components of this medicine (listed in section 6)
  • if you have a casein allergy, you should be aware that this medicine contains sodium caseinate
  • if you have a disease called primary carnitine deficiency.

Warnings and precautions

Consult your doctor or pharmacist before starting to take SPECTRACEF

  • if you have liver and/or kidney disease
  • if you are receiving anticoagulant therapy
  • if you have a history of gastrointestinal disease, particularly colitis
  • if you are receiving treatment with nephrotoxic agents such as aminoglycoside antibiotics or potent diuretics (such as furosemide), as these combinations may have undesirable effects on renal function and have been associated with ototoxicity.

Consult your doctor if you experience any of the following effects during treatment:

  • If during treatment you present any allergic reaction characterized by symptoms such as itching, redness, skin rash, swelling, or difficulty breathing.
  • If you experience diarrhea while taking this medicine or after completing treatment.

As with other antibiotics, prolonged treatment with SPECTRACEF may lead to an overgrowth of non-susceptible microorganisms, which requires discontinuation of treatment and the establishment of suitable therapy.

Treatment with SPECTRACEF may interfere with the results of some analytical tests, which may lead to false positives in:

  • The direct Coombs test.
  • Glucose determination in urine.

And false negatives in:

  • Glucose determination in blood or plasma.

Other medicines and SPECTRACEF

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine.

Between the administration of antacids and SPECTRACEF, it is recommended to leave a period of at least two hours.

The concomitant administration of SPECTRACEF with probenecid increases the amount of cefditoren in the blood.

The concomitant administration of SPECTRACEF with intravenous famotidine is not recommended, as it may hinder the achievement of the necessary amount in the blood.

Pregnancy and lactation

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. The administration of SPECTRACEF is not recommended during pregnancy or breastfeeding.

Driving and using machines

SPECTRACEF may cause dizziness and drowsiness, which may interfere with your ability to drive or operate any tool or machine.

SPECTRACEF 200 mg film-coated tablets contain sodium

This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially "sodium-free".

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take SPECTRACEF 200 mg film-coated tablets

Follow the administration instructions of this medicine indicated by your doctor or pharmacist exactly. In case of doubt, consult your doctor or pharmacist again. Remember to take your medicine. Your doctor will indicate the duration of treatment with SPECTRACEF.

Swallow the tablets whole, with a sufficient amount of liquid (a glass of water) during meals.

The recommended dose of this medicine and the frequency of administration are as follows:

Adults and adolescents (over 12 years)

  • Acute pharyngitis: 1 tablet (200 mg of cefditoren) every 12 hours for 10 days.
  • Acute maxillary sinusitis: 1 tablet (200 mg of cefditoren) every 12 hours for 10 days.
  • Acute exacerbation of chronic bronchitis: 1 tablet (200 mg of cefditoren) every 12 hours for 5 days.
  • Community-acquired pneumonia:
  • Mild cases: 1 tablet (200 mg of cefditoren) every 12 hours for 14 days.
  • Moderate cases: 2 tablets (400 mg of cefditoren) every 12 hours for 14 days.
  • Uncomplicated skin and soft tissue infections: 1 tablet (200 mg of cefditoren) every 12 hours for 10 days.

Use in children under 12 years

The use of SPECTRACEF has not been studied in patients under 12 years, so its administration is not recommended.

Elderly patients

In elderly patients, no dose adjustments are necessary except in cases of advanced hepatic and/or renal impairment.

Patients with renal insufficiency

No dose adjustment is necessary in patients with mild renal impairment. In patients with moderate renal insufficiency, do not exceed the dose of 1 tablet (200 mg of cefditoren) every 12 hours. In patients with severe renal insufficiency, a single dose of 1 tablet (200 mg of cefditoren) per day is recommended. The appropriate dose has not been determined in patients undergoing dialysis.

Patients with hepatic insufficiency

In mild or moderate hepatic insufficiency, it is not necessary to modify the treatment regimen. In cases of severe hepatic insufficiency, there are no data available to make a dose recommendation.

If you take more SPECTRACEF than you should

If you have taken more SPECTRACEF than recommended, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the package and leaflet of the medicine to the healthcare professional.

If you forget to take SPECTRACEF

In case you have forgotten a dose, take another as soon as possible and continue with the usual schedule. Do not take a double dose to make up for forgotten doses.

If you stop treatment with SPECTRACEF

Do not stop treatment before the duration indicated by your doctor, as there is a risk of relapse of the disease.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects may occur mainly of a gastrointestinal nature.

Very common (more than 1 in 10 people):

  • diarrhea.

Common (1 to 10 in 100 people):

  • headache, nausea, abdominal pain, feeling of indigestion, and vaginal infection.

Uncommon (1 to 10 in 1,000 people):

  • fungal infection
  • anorexia
  • nervousness, dizziness, and sleep disorders
  • pharyngitis, rhinitis, and sinusitis
  • constipation, flatulence, vomiting, oral candidiasis, eructation, dry mouth, and loss of taste
  • liver function alteration
  • skin rash, itching, and urticaria
  • vaginal inflammation and vaginal discharge
  • fever, weakness, and sweating
  • alterations in blood cell count (leukopenia and thrombocytosis), liver function test disorders (elevated ALT).

Rare (1 to 10 in 10,000 people):

  • hemolytic anemia and lymph node alteration
  • dehydration
  • demence, depersonalization, emotional weakness, euphoria, hallucinations, and increased libido
  • memory loss, discoordination, increased muscle tone, meningitis, and tremor
  • photosensitivity, visual acuity loss, eye pain, and eyelid inflammation
  • tinnitus
  • heart rhythm disorders, heart failure, and fainting
  • low blood pressure
  • asthma
  • oral ulcers, stomatitis, hemorrhagic colitis, ulcerative colitis, gastrointestinal bleeding, hiccups, tongue inflammation and discoloration, and diarrhea associated with Clostridium difficile
  • acne, hair loss, eczema, exfoliative dermatitis (cracked and scaly skin), and herpes simplex
  • muscle pain
  • urination pain, kidney inflammation, urination frequency disorders, incontinence, and urinary tract infection
  • breast pain, menstrual disorders, and erectile dysfunction
  • body odor and chills
  • alterations in blood cell count (eosinophilia, neutropenia, thrombocytopenia), coagulation disorders (prolongation of coagulation time, decrease in thromboplastin time, platelet alteration), liver function test disorders (increase in AST, alkaline phosphatase), or alterations in certain blood components (hyperglycemia, hypokalemia, bilirubinemia, increase in LDH, hypoproteinemia, increase in creatinine), or urine (albuminuria).

Frequency not known (cannot be estimated from available data):

  • pneumonia
  • Stevens-Johnson syndrome (blisters and erosion of the skin and mucous membranes)
  • skin redness
  • toxic epidermal necrolysis (severe form of Stevens-Johnson syndrome followed by skin pain and peeling of the upper layer of the skin)
  • acute kidney failure
  • anaphylactic shock
  • serum sickness-like reaction (late allergic reaction of the skin)
  • decrease in blood cells (agranulocytosis)
  • decrease in carnitine levels in the blood
  • cholestasis (obstruction of bile flow from the liver)
  • aplastic anemia (decrease in blood cell count)
  • liver damage
  • hepatitis.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's Pharmacovigilance System: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of SPECTRACEF 200 mg film-coated tablets

Keep this medicine out of the sight and reach of children.

Store in the original packaging.

Do not store above 30°C.

Do not use SPECTRACEF after the expiration date stated on the packaging. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Package contents and additional information

Composition of SPECTRACEF 200 mg film-coated tablets
  • The active ingredient is cefditoren. Each tablet contains 200 mg of cefditoren (as cefditoren pivoxil).
  • The other components are:

core: sodium caseinate, sodium croscarmellose, mannitol E421, sodium tripolyphosphate, and magnesium stearate.

coating: opadry Y-1-7000 (hypromellose, titanium dioxide E171, macrogol 400) and carnauba wax.

printing ink Opacode S-1-20986 blue: shellac, brilliant blue lacquer, titanium dioxide E171, propylene glycol, and concentrated ammonia solution.

Appearance of the product and package contents

SPECTRACEF 200 mg is presented in the form of film-coated tablets. Each package contains 16 or 20 tablets.

Only some pack sizes may be marketed.

Other presentations:

SPECTRACEF 400 mg film-coated tablets: each package contains 10 tablets.

Marketing authorization holder and manufacturer:

Meiji Pharma Spain, S.A.

Avda. de Madrid, 94.

28802 Alcalá de Henares, Madrid (Spain)

Date of the last revision of this leaflet:November 2020.

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es

Online doctors for SPECTRACEF 200 mg FILM-COATED TABLETS

Discuss questions about SPECTRACEF 200 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance. His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation. Patients commonly consult Dr Daniel Cichi for: 

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • sexually transmitted infections, erectile dysfunction;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders, weight loss, hair loss;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.

Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.

Camera Book a video appointment
€55
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for SPECTRACEF 200 mg FILM-COATED TABLETS?
SPECTRACEF 200 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SPECTRACEF 200 mg FILM-COATED TABLETS?
The active ingredient in SPECTRACEF 200 mg FILM-COATED TABLETS is cefditoren. This information helps identify medicines with the same composition but different brand names.
How much does SPECTRACEF 200 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for SPECTRACEF 200 mg FILM-COATED TABLETS is around 40.01 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures SPECTRACEF 200 mg FILM-COATED TABLETS?
SPECTRACEF 200 mg FILM-COATED TABLETS is manufactured by Meiji Pharma Spain S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SPECTRACEF 200 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SPECTRACEF 200 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SPECTRACEF 200 mg FILM-COATED TABLETS?
Other medicines with the same active substance (cefditoren) include MEIACT 200 mg FILM-COATED TABLETS, MEIACT 400 mg FILM-COATED TABLETS, SPECTRACEF 400 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media